Showing results (471-480 of 511) with videos related to
Sort By:
Pageof 52
Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancerDavid E Gerber, Mark A Socinski, Joel W Neal, et al.Cancer Discovery|February 26, 2021
Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II TrialGregory J Riely, Joel W Neal, D Ross Camidge, et al.JAMA Oncology|October 26, 2023
Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the USEunji Choi, Victoria Y Ding, Sophia J Luo, et al.Cancer|October 25, 2023
Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction modelEunji Choi, Sophia J Luo, Victoria Y Ding, et al.JCO Oncology Practice|July 21, 2026
Tobacco Use and Cessation Patterns Among Cancer Survivors: Results From Nine ECOG-ACRIN Cancer Research Group TrialsRachel L Rosen, Ju-Whei Lee, Ilana F Gareen, et al.Journal for Immunotherapy of Cancer|May 31, 2022
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesotheliomaRamaswamy Govindan, Charu Aggarwal, Scott J Antonia, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2018
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical OutcomesNicolas Marcoux, Scott N Gettinger, Grainne O'Kane, et al.Journal for Immunotherapy of Cancer|July 18, 2018
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)Julie R Brahmer, Ramaswamy Govindan, Robert A Anders, et al.Nature Communications|June 11, 2016
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patientsJacob J Chabon, Andrew D Simmons, Alexander F Lovejoy, et al.Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
Molecular profiling of single circulating tumor cells from lung cancer patientsSeung-Min Park, Dawson J Wong, Chin Chun Ooi, et al.Pageof 52